Wake Forest University spinout Renovo closed the round at $6.4m and will put the funding into further development of its brain injury treatment system.
Renovo Concepts, A US-based medical device developer leveraging research from Wake Forest University’s School of Medicine, has collected $6.4m of funding from undisclosed investors to close its series A round.
Founded in 2017, Renovo is developing and commercialising a mechanical tissue resuscitation (MTRTM) devices designed to treat traumatic brain injuries.
The company’s MTRTM treatments are derived from research conducted by Louis Argenta, the founder of the department of plastic and reconstructive surgery at Wake Forest University’s School of Medicine, and Michael Morykwas, a former director of research at the same department.
Renovo plans to use the funding for product development, manufacturing activities and a first-in-human safety study for its MTRTM device.
The spinout received $1.3m of funding from two undisclosed investors in June 2020, according to a regulatory filing. It had previously secured $50,000 in seed funding from San Antonio Military Medical Innovation Fund in late…
